Osami Kono
Directeur/Bestuurslid bij Luxonus Co., Ltd.
Profiel
Osami Kono currently works at Luxonus Co., Ltd., as Director, EneCoat Technologies Co., Ltd., as Outside Director from 2018, Rege Nephro Co. Ltd., as Outside Director, and Kyoto University Innovation Capital Co., Ltd., as Investment Manager from 2016.
Actieve functies van Osami Kono
Bedrijven | Functie | Begin |
---|---|---|
Kyoto University Innovation Capital Co., Ltd.
Kyoto University Innovation Capital Co., Ltd. Investment ManagersFinance Kyoto University Innovation Capital Co., Ltd. (KYOTO-iCAP) is a Venture Capital firm, a subsidiary of Kyoto University founded in 2014. Kyoto University Innovation Capital Co., Ltd. is headquartered in Kyoto. | Private Equity Investor | 01-04-2016 |
EneCoat Technologies Co., Ltd.
EneCoat Technologies Co., Ltd. SemiconductorsElectronic Technology EneCoat Technologies Co., Ltd. is a company based in Kyoto, Japan that focuses on developing materials for perovskite solar cells and manufacturing modules. The Japanese company aims to promote the effective use of natural energy and protect the environment to create a better future. EneCoat Technologies Co. was founded in 2018 by Atsushi Wakamiya and Naoya Kato, with Naoya Kato serving as the CEO since then. | Directeur/Bestuurslid | 01-12-2018 |
Luxonus Co., Ltd.
Luxonus Co., Ltd. Electronics/AppliancesConsumer Durables Luxonus Co., Ltd. manufactures photo acoustic imaging products. The company is based in Kawasaki, Japan. The Japanese company was founded by Sadakazu Aiso. | Directeur/Bestuurslid | - |
Rege Nephro Co. Ltd.
Rege Nephro Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Rege Nephro Co. Ltd. is a company based in Kyoto, Japan that specializes in the research, development, production, and sales of renal disease treatment drugs. The Japanese company has developed a unique and realistic approach to induce high-efficiency differentiation from stem cells, with the aim of saving patients suffering from renal failure. The company's research and development activities focus on developing various solutions for renal disease and improving the quality of life of patients suffering from renal disease. Rege Nephro Co. was founded in 2019 by Kenji Nagafune. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Kyoto University Innovation Capital Co., Ltd.
Kyoto University Innovation Capital Co., Ltd. Investment ManagersFinance Kyoto University Innovation Capital Co., Ltd. (KYOTO-iCAP) is a Venture Capital firm, a subsidiary of Kyoto University founded in 2014. Kyoto University Innovation Capital Co., Ltd. is headquartered in Kyoto. | Finance |
EneCoat Technologies Co., Ltd.
EneCoat Technologies Co., Ltd. SemiconductorsElectronic Technology EneCoat Technologies Co., Ltd. is a company based in Kyoto, Japan that focuses on developing materials for perovskite solar cells and manufacturing modules. The Japanese company aims to promote the effective use of natural energy and protect the environment to create a better future. EneCoat Technologies Co. was founded in 2018 by Atsushi Wakamiya and Naoya Kato, with Naoya Kato serving as the CEO since then. | Electronic Technology |
Luxonus Co., Ltd.
Luxonus Co., Ltd. Electronics/AppliancesConsumer Durables Luxonus Co., Ltd. manufactures photo acoustic imaging products. The company is based in Kawasaki, Japan. The Japanese company was founded by Sadakazu Aiso. | Consumer Durables |
Rege Nephro Co. Ltd.
Rege Nephro Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Rege Nephro Co. Ltd. is a company based in Kyoto, Japan that specializes in the research, development, production, and sales of renal disease treatment drugs. The Japanese company has developed a unique and realistic approach to induce high-efficiency differentiation from stem cells, with the aim of saving patients suffering from renal failure. The company's research and development activities focus on developing various solutions for renal disease and improving the quality of life of patients suffering from renal disease. Rege Nephro Co. was founded in 2019 by Kenji Nagafune. | Commercial Services |